Possible anxiolytic effects of taurine in the mouse elevated plus-maze
Introduction
Taurine, 2-aminoethane-sulphonic acid, is one of the few sulfur-containing amino acids that is found in relatively high concentrations in the central nervous system of mammals. This amino acid has been shown to be essential for the development, survival, growth of vertebrate neurons (Hayes et al., 1975). Taurine deficiency has been confirmed in many neuropathological conditions, such as epilepsy Barbeau et al., 1975, Joseph and Emson, 1976, mental depression (Perry, 1976), and the alcohol withdrawal syndrome (Ikeda, 1977). It has been reported that taurine contents in brain increased significantly at the onset of convulsions, as induced by tossing the animals up many times. On the other hand, taurine administration increased the threshold of convulsion by the stimulation in E1 mice (Iwata et al., 1979). Taurine (2 g/kg, PO) can significantly prolong the latency of convulsion induced by strychnine (Fonnum, 1978) and the pentobarbital sleeping time in mice (Zhang et al., 1981). In open-field test, Sanberg et al. reported that increasing doses of taurine significantly decreased ambulation levels, increased latency scores, and increased thigmotaxis (Sanberg and Ossenkopp, 1977).
In the past ten years, more and more researches were focused on the interaction of taurine with GABA system. Taurine competitively inhibited [3H]muscimol binding to purified GABAA receptors with an IC50 value of 50 μM, it showed notably a higher affinity for β55 polypeptide (Bureau and Olsen, 1991). Moreover, it has been found that taurine interacted with GABAA receptor-linked benzodiazepine receptor binding sites (Medina and DeRobertis, 1984). An inhibition of GABAB binding sites at 1–5 μM taurine also was observed (Kontro and Oja, 1990). Since the fact of Gabaergic-Benzodiazepine system involved in the aetiology of anxiety has been widely accepted, taurine is a chemical analogue and imitates the action of GABA, it might be also concerned with anxiety. So we are interested in the relationship between taurine and anxiety. The main purpose of this study is to examine the effects of taurine on the behavior of mice in the elevated plus-maze, a most commonly used animal models of anxiety. Besides the conventional methods to index the level of anxiety and general activity on the plus-maze (Lister, 1987), some other ethological measures have been developed to improve the sensitivity of the model (Cole and Rodgers, 1994). In our present study, both traditional and novel measures were adopted to observe the drug effects.
Section snippets
Animals
Male Swiss mice (Experimental Animal center of Shenyang Pharmaceutical University) weighing 14–16 g were housed in groups of 5 in polycarbonate cages (cage size: 25 × 14 × 12 cm) for at least 10 days prior to testing. The Animal house was maintained under a 12 h reversed light cycle (light off 07:00) at room temperature 22 ± 2 °C. Food and water were freely available at all times except for brief test periods. Each animal was used only once, and at testing, weighed 20–22 g.
Drugs
Taurine,
Taurine
Data are summarized in Fig. 1 and Table 1. Analysis revealed that single administration of 60 mg/kg taurine significantly increased percent open arm time [F (4,46) = 2.82, P < 0.05] and decreased total rears [F (4,47) = 3.04, P < 0.05]. Although there was an apparent increase in percent open arm entries (60 mg/kg), F values failed to reach an acceptable level of statistical significance.
Diazepam
Data are summarized in Fig. 1 and Table 2. ANOVA showed significant treatment effects for open arm entries [F
Discussion
The present study demonstrates that taurine has an anxiolytic-like profile in the elevated plus-maze test in mice. However, the anti-anxiety effect of taurine appears to be mild and limited comparing to its other CNS effects, such as anticonvulsant effect.
The elevated plus-maze is a well-established animal model for testing anxiolytic drugs Dawson and Tricklebank, 1995, Kulkarni and Reddy, 1996. In the test, the percentage of entries into open arms and of time spent in open arms have generally
References (27)
- et al.
Taurine transport at the blood-brain barrier: an in vivo brain perfusion study
Brain Research
(1995) - et al.
Taurine acts on a subclass of GABAA receptors in mammalian brain in vitro
European Journal of Pharmacology
(1991) - et al.
Anxiolytic-like effect of succinic acid in mice
Life Sciences
(2003) - et al.
Use of the elevated plus-maze in the search for novel anxiolytic agents
Trends in Pharmacological Sciences
(1995) Effects of taurine on alcohol withdrawal
Lancet
(1977)- et al.
Increase of brain taurine contents of E1 mice by physiological stimulation
Japanese Journal of Pharmacology
(1979) - et al.
Interactions of taurine with GABAB binding site in mouse brain
Neuropharmacology
(1990) - et al.
Mulitiple-test study of anxiety-related behaviours in six inbred rat strains
Behavioral Brain Research
(1997) - et al.
Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze
Pharmacology Biochemistry and Behavior
(1995) - et al.
Anxiogenic stimuli in the elevated plus-maze
Pharmacology Biochemistry and Behavior
(1993)
The neuropharmacology of taurine
Life Sciences
Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol
Psychopharmacology
Cited by (49)
Acute taurine reduced alcohol intake and preference in alcohol-experienced, but not in alcohol-näive rats by central mechanisms
2024, Behavioural Brain ResearchTherapeutic potential of glutathione-enhancers in stress-related psychopathologies
2020, Neuroscience and Biobehavioral ReviewsEnergy drink constituents (caffeine and taurine) selectively potentiate ethanol-induced locomotion in mice
2019, Pharmacology Biochemistry and BehaviorCitation Excerpt :Low doses of taurine were shown both to decrease (1 g/kg ethanol) and increase (2 g/kg ethanol) ethanol-induced locomotor activity (Aragon et al., 1992). Low doses of taurine have also been shown to decrease ethanol-induced sleeping time, while increasing the time spent in the open arms of the elevated plus-maze (Boggan et al., 1978; Chen et al., 2004). Very high doses of taurine (>400 mg/kg) have been shown to decrease locomotor activity, and may, depending on route of administration and time-point of taurine treatment, both increase as well as decrease ethanol-induced sleeping time (McBroom et al., 1986; Ginsburg and Lamb, 2008; Whirley and Einat, 2008).
Nucleus accumbens neurochemistry in human anxiety: A 7 T <sup>1</sup> H-MRS study
2019, European NeuropsychopharmacologyCitation Excerpt :In this 7 T 1H-MRS study of the human NAc, we report a marked positive correlation between trait anxiety and NAc taurine content, and a negative correlation between perceived situational stress and NAc GABA, while positive with the Glu/GABA ratio. Our finding linking NAc taurine concentrations with natural variations in trait anxiety in healthy humans seems remarkable, given the existence of studies in rodents (Chen et al., 2004; El Idrissi et al., 2009; Kong et al., 2006; Zhang and Kim, 2007) and zebrafish (Mezzomo et al., 2016, 2017) that have reported reductions in anxiety-like behaviors following treatment with taurine. Taurine can exert inhibitory neuromodulatory actions through its weak agonistic effects on GABAA and glycine receptors (Bhattarai et al., 2015; Chan et al., 2014; Jia et al., 2008) [also note additional evidence of taurine's partial agonistic actions on NMDA receptors (Mezzomo et al., 2017)].
Energy drink and alcohol combination leads to kidney and liver alterations in rats
2018, Toxicology and Applied Pharmacology